The Long Run with Luke Timmerman

A podcast by Timmerman Report

173 Episodes

  1. Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's

    Published: 3/6/2024
  2. Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer

    Published: 2/9/2024
  3. Ep153: Rick Young on Studying Gene Expression for Drug Discovery

    Published: 1/22/2024
  4. Ep152: Jens Eckstein on Investing in Healthy Aging

    Published: 1/10/2024
  5. Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

    Published: 12/26/2023
  6. Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance

    Published: 12/13/2023
  7. Ep149: Nancy Stagliano on Precision Neuroscience

    Published: 11/29/2023
  8. Ep148: Diana Brainard on the Fight Against Infectious Disease

    Published: 11/13/2023
  9. Ep147: Reid Huber on Investing in the Future of Medicine

    Published: 11/1/2023
  10. Ep146: Jeff Huber on Life in Tech and Biotech

    Published: 10/17/2023
  11. Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer

    Published: 10/3/2023
  12. Ep144: Turning the Tables, Rob Perez Interviews Me

    Published: 9/19/2023
  13. Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders

    Published: 9/6/2023
  14. Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be

    Published: 8/24/2023
  15. Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets

    Published: 8/8/2023
  16. Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas

    Published: 7/24/2023
  17. Ep139: Kevin Conroy on Early Detection of Cancer

    Published: 7/10/2023
  18. Ep138: Jodie Morrison on Becoming a Biotech CEO

    Published: 6/27/2023
  19. Ep137: Aaron Ring on Immunotherapy for Cancer & More

    Published: 6/14/2023
  20. Ep136: Deborah Palestrant on Building Biotech Startups

    Published: 5/30/2023

2 / 9

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.